Resverlogix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:RFS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 24Sell€5,163Aaron CannIndividual125,000€0.041

Insider Trading Volume

Insider Buying: RFS insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of RFS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,045,0832.51%
Institutions27,712,8799.87%
Public Companies85,286,52430.4%
General Public160,605,70857.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.


Top Shareholders

Top 6 shareholders own 42.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30.4%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
85,286,524€3.4m0%no data
9.87%
Eastern Capital Limited
27,712,879€1.1m0%19.06%
1.88%
Donald McCaffrey
5,263,266€212.1k0%no data
0.56%
Aaron Cann
1,569,755€63.3k16.7%no data
0.038%
Kenneth Zuerblis
107,062€4.3k0%no data
0.037%
Kelly McNeill
105,000€4.2k0%no data